Ignite Creation Date:
2024-05-06 @ 1:00 PM
Last Modification Date:
2024-10-26 @ 1:07 PM
Study NCT ID:
NCT03907618
Status:
COMPLETED
Last Update Posted:
2019-04-09
First Post:
2019-04-06
Brief Title:
Evaluation of HbA1c Levels and Ovarian Reserve and Type 1 Diabetes
Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Organization:
Kanuni Sultan Suleyman Training and Research Hospital
Study Overview
Official Title:
Evaluation of HbA1c Levels and Ovarian Reserve in Patients With Type 1 Diabetes Diagnosis
Status:
COMPLETED
Status Verified Date:
2019-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The human ovary is the target of an autoimmune attack usually in organ or non-specific autoimmune disorders Serum anti-Müllerian hormone AMH levels decrease early in menopause and menopause is seen in women with type 1 diabetes mellitus DM1 at a young age DM1 is aimed to show DM1 relationship with ovarian reserve based on the assumption that it will have lower AMH levels than controls secondary to bad glycemic control and autoimmune attack in women
Detailed Description:
The study was designed prospectively Ovarian functions in healthy volunteer women and patients who use DM1 diagnosed between 18-40 years old will be examined Gonadotropin and AMH levels will be measured in follicular phase To calculate the number of antral follicles AFC and ovarian volume ultrasound will be looked at Fasting and satiety blood glucose HbA1c and C-peptide levels will be evaluated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None